What is the role of the International Prognostic Index (IPI) in the prognosis of NHL/B-cell lymphoma?

Updated: Feb 23, 2021
  • Author: Mohammad Muhsin Chisti, MD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The IPI was originally designed as a prognostic factor model for aggressive NHL, but can be useful for predicting the outcome of patients with low-grade lymphoma. This index is also used to identify patients at high risk of relapse based on specific sites of involvement, including bone marrow, central nervous system, liver, testis, lung, and spleen. [9] Separate indices have been developed for follicular and mantle cell lymphoma. [10, 11, 12]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!